Haleon plc (HLNN.MX)
| Previous Close | 66.02 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's Range | 66.02 - 66.02 |
| 52 Week Range | 66.02 - 66.02 |
| Volume | |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Haleon Canada & GlobalMedic Launch Haleon Health Trailer
Today, Haleon (Canada), a global leader in consumer health; makers of Advil, Voltaren, Centrum, Buckley's and Sensodyne; have partnered with GlobalMedic to launch the first ever Haleon Health Trailer focused on providing self-care products and services to marginalized communities. The health trailer will help to progress Haleon's goal of empowering Canadians to be more included in opportunities for better everyday health.
- PR Newswire
Abreva Drops One-of-a-Kind Pair of Diamond Lips, Inspired by the Cold Sore Experience
Abreva is encouraging consumers to rock their cold sores with confidence, unveiling a highly covetable, one-of-a-kind pair of diamond lips. The bejeweled piece is fashioned to destigmatize a condition that many are ashamed to discuss, let alone flaunt. In fact, 2/3 of young cold sore sufferers say their self-esteem and confidence is shaken when a cold sore strikes1.
- PR Newswire
Yellow Wood Partners Portfolio Company Suave Brands Company Acquires ChapStick from Haleon
Yellow Wood Partners ("Yellow Wood"), a Boston-based private equity firm focused on investing in consumer brands and companies, today announced that its portfolio company Suave Brands Company has signed a binding offer to acquire the ChapStick brand from Haleon (LSE / NYSE: HLN), a global leader in consumer health. The transaction is intended to close in the first half of 2024 upon completion of customary closing and regulatory approvals.
